Cargando…

Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

BACKGROUND: Massive bleeding is one of the commonest salvageable causes of death. The search for an ideal haemostatic agent during massive bleeding is still ongoing. One of the novel haemostatic medications is recombinant activated factor VII (rFVIIa). To date, the usage of rFVIIa during massive hae...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Nurfatin Mohd, Chong, Soon Eu, Yusoff, Syahirah Mohamed, Mazlan, Mohd Zulfakar, Johan, Khairul Bariah, Azman, Nizuwan, Lim, Jo Anne, Mohamad, Siti Mardhiana, Noordin, Siti Salmah, Ghaffar, Zainab Abdul, Hassan, Mohd Hasyizan, Zabidi, Muhammad Azrul, Rahim, Nur Arzuar Abdul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251212/ https://www.ncbi.nlm.nih.gov/pubmed/30498571 http://dx.doi.org/10.1186/s12878-018-0126-z

Ejemplares similares

Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
por: Montacir, Othman, et al.
Publicado: (2018)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Regional variation of the off-licence use of rFVIIa for patients with uncontrolled haemorrhage in England
por: Spivey, MH, et al.
Publicado: (2010)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood
por: Haidl, Harald, et al.
Publicado: (2019)

Validity and reliability of knowledge, attitude, and practice regarding exercise and exergames experiences questionnaire among high school students
por: Abdulkader Mohamed, Rwayda, et al.
Publicado: (2022)

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
por: Ng, Heng Joo, et al.
Publicado: (2006)

Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
por: Smith, Jason E, et al.
Publicado: (2019)

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
por: Linari, Silvia, et al.
Publicado: (2020)

Blood transfusion services amidst the COVID-19 pandemic
por: Noordin, Siti Salmah, et al.
Publicado: (2021)

Comparison of Esmolol and Dexmedetomidine Infusion in Attenuating Haemodynamic and Blood Glucose Response to Laryngoscopy and Intubation: A Single Blinded Study
por: Koh, Vincent, et al.
Publicado: (2021)

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
por: Poon, Man-Chiu
Publicado: (2007)

Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
por: Bonadona, A, et al.
Publicado: (2002)

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
por: Nicosia, Dario, et al.
Publicado: (2019)

Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses
por: Kjalke, Marianne, et al.
Publicado: (2021)

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm
por: Heslet, Lars, et al.
Publicado: (2012)

Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
por: Bomken, Charlotte, et al.
Publicado: (2009)

Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury
por: Kim, Bobby, et al.
Publicado: (2014)

Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
por: Milošević, Danko, et al.
Publicado: (2014)

Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018)

Revision Arthroplasty in the Haemophiliac Patient
por: Molloy, A. P., et al.
Publicado: (2013)

Treatment of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus Patient With Local Pulmonary Administration of Factor VIIa (rFVIIa): A Case Report
por: Alabed, Iehab B.
Publicado: (2014)

Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa: A case report
por: Ma, Hongbing, et al.
Publicado: (2021)

Postoperative Maladaptive Behavior, Preoperative Anxiety and Emergence Delirium in Children Undergone General Anesthesia: A Narrative Review
por: Zainal Abidin, Huda, et al.
Publicado: (2021)

Comparing the Effects of Pre-loading with Gelatine 4% Plasma Volume Expander and 6% Hydroxyethyl Starch Solution Before Spinal Anaesthesia for Lower Limb Orthopaedic Surgery
por: Md Nizar, Nur Dyana, et al.
Publicado: (2020)

Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system organ failure and acute upper gastrointestinal bleeding
por: Milanov, S, et al.
Publicado: (2003)

Oral and Psychological Alterations in Haemophiliac Patients
por: Fiorillo, Luca, et al.
Publicado: (2019)

Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
por: Krzyżanowski, Arkadiusz, et al.
Publicado: (2022)

Enhancement of Tech-Sil25 Maxillofacial Silicone Mechanical Properties after Artificial Weathering through Addition of Nanoparticles
por: Fadhil Bunyan, Shahad, et al.
Publicado: (2022)

Fallen lung sign in a traumatic partial bronchial tear: A case report
por: Sayuti, Khairil Amir, et al.
Publicado: (2022)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran: A cost–utility analysis
por: Saiyarsarai, Parisa, et al.
Publicado: (2021)

Missed by RTK, caught by PCR, unimagined chest Radiograph
por: Mazlan, Mohd Zulfakar, et al.
Publicado: (2021)

Immune response to multiple skin test antigens in haemophiliacs
por: McIvor, R A, et al.
Publicado: (1987)

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)
por: Rajpurkar, Madhvi, et al.
Publicado: (2019)

Systematic Review on the Effects, Roles and Methods of Magnetic Particle Coatings in Magnetorheological Materials
por: Jamari, Siti Khumaira Mohd, et al.
Publicado: (2020)

Microbiological Safety of Street-Vended Beverages in Chow Kit, Kuala Lumpur
por: Mohd Nawawee, Nur Syakirah, et al.
Publicado: (2019)

Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient
por: Bacci, Christian, et al.
Publicado: (2021)

Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial
por: Kluger, Yoram, et al.
Publicado: (2007)

Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa)
por: Kyang, Lee S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m63ddvspilnranejlc9uf96ulo